SNO ONLINE EDUCATION CENTER
The SNO Online Education center promotes advancement in neuro-oncology research and education by providing access to online resources. We continue to expand this online learning center with a broad range of topics and speakers that will enhance the scientific and clinical expertise within the field of neuro-oncology.
SNO takes a multidisciplinary approach to continuing education by providing opportunities for CME credit through webinars, special events or publications. Please see the section below titled Continuing Education
for options as they become available.
ANNUAL MEETING CONTENT
Select presentations from the 2017 and 2018 SNO Annual Meeting are free to view by clicking on the links below. Those registered for the 2018 SNO Annual Meeting can view all of the presentations from the New Orleans conference by clicking here.
2018 Annual Meeting
2017 Annual Meeting
Select Presentations by Category:
You may also access presentations through this link, https://soc-neuro-onc.vids.io/
, and select the "Browse by Categories" drop-down menu located at the upper right of the page.
Supplemental Issue of Neuro-Oncology
with free CME Credit: Survivorship in Neuro-Oncology: Improving Care by Advancing Science
According to the National Cancer Institute, an individual is considered a cancer survivor from the time of diagnosis through the balance of his or her life. Essential components of survivorship care include prevention of recurrent cancer and late effects, surveillance for cancer recurrence and assessment, and interventions for management of late psychological and medical effects. There is a paucity of literature related to these topics in neuro-oncology. This supplement to SNO’s official journal, Neuro-Oncology
, includes manuscripts that provide an overview of these essential components specifically in neuro-oncology. To access the Survivorship Supplement, click here.
Available to current SNO members.
Not a member? For information on joining SNO, click here.
Neuro-Oncology Oligodendroglioma Tumor Board
National Cancer Institute, November 19, 2018